Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:6 (5 January), doi:10.1136/bmj.39386.664016.BE
Are strongly linked, but the precise mechanisms are unclear
| The first 150 words of the full text of this article appear below. |
The Dementia UK report, published earlier this year on behalf of the Alzheimers Society, predicts that by 2050, 34 million people worldwide will have dementia, and 71% of these people will live in developing countries.1 Currently, nearly 700 000 people have dementia in the United Kingdom, and worldwide this figure approaches 18 million. Dementia costs the UK economy around £17bn (
24bn; $35bn) each year, but the human cost to patients, their families, and their friends is incalculable.
Over the past 15 years, several studies have indicated that diabetes mellitus, particularly type 2 diabetes, is associated with an increased risk of cognitive impairment and dementia.234 If these studies are correct, then the future burden of dementia may be even greater than estimated as the prevalence of type 2 diabetes continues to rise.
Early data that linked type 2 diabetes with cognitive impairment came from cross sectional cohort studies that were
Mark W J Strachan, consultant physician1, Jacqueline F Price, clinical senior lecturer in epidemiology2, Brian M Frier, honorary professor of diabetes3
1 Metabolic Unit, Western General Hospital, Edinburgh EH4 2XU, 2 University of Edinburgh, Edinburgh EH8 9AG, 3 Royal Infirmary of Edinburgh, Edinburgh EH16 4SG
mark.strachan@luht.scot.nhs.uk
Read all Rapid Responses
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.